Cargando…

Modulation of Dopamine Receptors on Osteoblasts as a Possible Therapeutic Strategy for Inducing Bone Formation in Arthritis

Rheumatoid arthritis (RA) is associated with systemic osteoporosis, which leads to severe disability and low quality of life. Current therapies target osteoclasts to reduce bone degradation, but more treatment options would be required to promote bone protection by acting directly on osteoblasts (OB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwendich, Elena, Salinas Tejedor, Laura, Schmitz, Gernot, Rickert, Markus, Steinmeyer, Jürgen, Rehart, Stefan, Tsiami, Styliani, Braun, Jürgen, Baraliakos, Xenofon, Reinders, Jörg, Neumann, Elena, Müller-Ladner, Ulf, Capellino, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140103/ https://www.ncbi.nlm.nih.gov/pubmed/35626646 http://dx.doi.org/10.3390/cells11101609

Ejemplares similares

Dopamine receptor 1 expressing B cells exert a proinflammatory role in female patients with rheumatoid arthritis
por: Wieber, Karolin, et al.
Publicado: (2022)

Dopamine induces in vitro migration of synovial fibroblast from patients with rheumatoid arthritis
por: van Nie, Lina, et al.
Publicado: (2020)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases
por: Kiltz, Uta, et al.
Publicado: (2022)

Pearls and Pitfalls in Diagnosing Non-Radiographic Axial Spondyloarthritis
por: Tsiami, Styliani, et al.
Publicado: (2022)

High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis
por: Krekeler, Martin, et al.
Publicado: (2022)

New developments in ankylosing spondylitis—status in 2021
por: Klavdianou, Kalliopi, et al.
Publicado: (2021)

Erratum to: New developments in Ankylosing spondylitis – Status in 2021
por: Klavdianou, Kalliopi, et al.
Publicado: (2022)

Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care
por: Redeker, Imke, et al.
Publicado: (2023)

Free Fatty Acids in Bone Pathophysiology of Rheumatic Diseases
por: Frommer, Klaus W., et al.
Publicado: (2019)

Real‐world evidence for subcutaneous infliximab (CT‐P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID‐19) pandemic: A case series
por: Baraliakos, Xenofon, et al.
Publicado: (2022)

Serum granulocyte-macrophage colony-stimulating factor (GM-CSF) is increased in patients with active radiographic axial spondyloarthritis and persists despite anti-TNF treatment
por: Papagoras, Charalampos, et al.
Publicado: (2022)

Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study
por: Kiltz, Uta, et al.
Publicado: (2021)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
por: Braun, Jürgen, et al.
Publicado: (2022)

Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts
por: Neumann, Elena, et al.
Publicado: (2010)

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
por: Braun, Jürgen, et al.
Publicado: (2021)

Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib
por: Diller, Magnus, et al.
Publicado: (2019)

SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD
por: Roman, Iulia, et al.
Publicado: (2022)

Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine
por: Capellino, Silvia, et al.
Publicado: (2020)

Functional MR imaging beyond structure and inflammation—radiographic axial spondyloarthritis is associated with proteoglycan depletion of the lumbar spine
por: Abrar, Daniel B., et al.
Publicado: (2020)

Collagen Metabolism of Human Osteoarthritic Articular Cartilage as Modulated by Bovine Collagen Hydrolysates
por: Schadow, Saskia, et al.
Publicado: (2013)

Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial
por: Trampisch, Ulrike S, et al.
Publicado: (2014)

Do patients with ankylosing spondylitis adapt to their disease? Evidence from a ‘then-test’ in patients treated with TNF inhibitors
por: Essers, Ivette, et al.
Publicado: (2015)

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness‐to‐Pay Approach
por: Webers, Casper, et al.
Publicado: (2018)

Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1
por: Braun, Jürgen, et al.
Publicado: (2021)

Evaluation of Sodium Relaxation Times and Concentrations in the Achilles Tendon Using MRI
por: Kamp, Benedikt, et al.
Publicado: (2022)

The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts
por: Diller, Magnus, et al.
Publicado: (2019)

Wie gut sind Patienten mit entzündlich rheumatischen Erkrankungen gegen Masern geschützt?
por: Kiltz, U., et al.
Publicado: (2020)

Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study
por: Braun, Jürgen, et al.
Publicado: (2019)

Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs
por: Steinmeyer, Jürgen
Publicado: (2000)

The Effect of Dexamethasone, Adrenergic and Cholinergic Receptor Agonists on Phospholipid Metabolism in Human Osteoarthritic Synoviocytes
por: Sluzalska, Katarzyna D., et al.
Publicado: (2019)

Developments in the synovial biology field 2006
por: Knedla, Anette, et al.
Publicado: (2007)

Certolizumab pegol treatment in axial spondyloarthritis mitigates fat lesion development: 4-year post-hoc MRI results from a phase 3 study
por: Baraliakos, Xenofon, et al.
Publicado: (2021)

Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
por: van der Heijde, Désirée, et al.
Publicado: (2019)

Adipocytokines and autoimmunity
por: Frommer, Klaus W, et al.
Publicado: (2011)

Clinically relevant advances in rheumatoid arthritis therapy
por: Müller-Ladner, Ulf, et al.
Publicado: (2009)

Rheumatologische Weiterbildungsstellen in Deutschland
por: Pfeil, Alexander, et al.
Publicado: (2022)

A comparative study on the lipidome of normal knee synovial fluid from humans and horses
por: Kosinska, Marta K., et al.
Publicado: (2021)

The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
por: Baraliakos, Xenofon, et al.
Publicado: (2008)

Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study
por: Inman, Robert D., et al.
Publicado: (2016)

Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis – the TryCort study
por: Kiltz, Uta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qvvfa51sdfapkb145nuft9g5ls